These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38576594)

  • 41. Sodium Butyrate Induces CRC Cell Ferroptosis via the CD44/SLC7A11 Pathway and Exhibits a Synergistic Therapeutic Effect with Erastin.
    Bian Z; Sun X; Liu L; Qin Y; Zhang Q; Liu H; Mao L; Sun S
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment.
    Jiang H; Tian H; Wang Z; Li B; Chen R; Luo K; Lu S; Nice EC; Zhang W; Huang C; Zhou Y; Zheng S; Gao F
    Biomater Res; 2023 Sep; 27(1):92. PubMed ID: 37742011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A biomimetic nanodrug self-assembled from small molecules for enhanced ferroptosis therapy.
    Xu X; Chen Y; Gui J; Liu P; Huang Y; Shao B; Ping Y; Li B
    Biomater Sci; 2022 Feb; 10(3):770-780. PubMed ID: 34988569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
    Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
    Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
    Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
    Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer.
    Ozkan E; Bakar-Ates F
    Curr Med Chem; 2022; 29(1):41-55. PubMed ID: 34375173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy.
    Liao Z; Wen E; Feng Y
    J Nanobiotechnology; 2024 Apr; 22(1):147. PubMed ID: 38570829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ferroptosis-Associated Molecular Features to Aid Patient Clinical Prognosis and Therapy Across Human Cancers.
    Cui K; Gong L; Wang K; Wang Y; Huang L; Liu B; Li Q; Zhang Q; Fei B; Huang Z
    Front Immunol; 2022; 13():888757. PubMed ID: 35812384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
    Zhu L; Meng D; Wang X; Chen X
    ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
    Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
    Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
    Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
    Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway.
    Zhao L; Miao H; Quan M; Wang S; Zhang Y; Zhou H; Zhang X; Lin Z; Piao J
    Chem Biol Interact; 2024 Feb; 389():110866. PubMed ID: 38218311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer.
    Deng K; Tian H; Zhang T; Gao Y; Nice EC; Huang C; Xie N; Ye G; Zhou Y
    J Control Release; 2024 Feb; 366():684-693. PubMed ID: 38224739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
    Shibata Y; Yasui H; Higashikawa K; Miyamoto N; Kuge Y
    PLoS One; 2019; 14(12):e0225931. PubMed ID: 31800616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer.
    Li H; Yu K; Hu H; Zhang X; Zeng S; Li J; Dong X; Deng X; Zhang J; Zhang Y
    Redox Biol; 2024 May; 71():103087. PubMed ID: 38377789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy.
    Zhao Y; Li Y; Zhang R; Wang F; Wang T; Jiao Y
    Onco Targets Ther; 2020; 13():5429-5441. PubMed ID: 32606760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling.
    Tian X; Li S; Ge G
    Cancer Manag Res; 2021; 13():1333-1342. PubMed ID: 33603479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression.
    He Y; Ling Y; Zhang Z; Mertens RT; Cao Q; Xu X; Guo K; Shi Q; Zhang X; Huo L; Wang K; Guo H; Shen W; Shen M; Feng W; Xiao P
    Redox Biol; 2023 Sep; 65():102822. PubMed ID: 37494767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanoparticle ferritin-bound erastin and rapamycin: a nanodrug combining autophagy and ferroptosis for anticancer therapy.
    Li Y; Wang X; Yan J; Liu Y; Yang R; Pan D; Wang L; Xu Y; Li X; Yang M
    Biomater Sci; 2019 Aug; 7(9):3779-3787. PubMed ID: 31211307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
    Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
    Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.